SG11202000593TA - Liposome compositions comprising weak acid drugs and uses thereof - Google Patents
Liposome compositions comprising weak acid drugs and uses thereofInfo
- Publication number
- SG11202000593TA SG11202000593TA SG11202000593TA SG11202000593TA SG11202000593TA SG 11202000593T A SG11202000593T A SG 11202000593TA SG 11202000593T A SG11202000593T A SG 11202000593TA SG 11202000593T A SG11202000593T A SG 11202000593TA SG 11202000593T A SG11202000593T A SG 11202000593TA
- Authority
- SG
- Singapore
- Prior art keywords
- weak acid
- liposome compositions
- acid drugs
- drugs
- liposome
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762536034P | 2017-07-24 | 2017-07-24 | |
| US201762595207P | 2017-12-06 | 2017-12-06 | |
| PCT/US2018/043221 WO2019023092A1 (en) | 2017-07-24 | 2018-07-23 | Liposome compositions comprising weak acid drugs and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202000593TA true SG11202000593TA (en) | 2020-02-27 |
Family
ID=65014326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202000593TA SG11202000593TA (en) | 2017-07-24 | 2018-07-23 | Liposome compositions comprising weak acid drugs and uses thereof |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11964050B2 (en) |
| EP (1) | EP3658134A4 (en) |
| JP (1) | JP6974670B2 (en) |
| KR (1) | KR102337566B1 (en) |
| CN (1) | CN111372580A (en) |
| AU (1) | AU2018307509B2 (en) |
| BR (1) | BR112020001411A2 (en) |
| CA (1) | CA3070951C (en) |
| IL (1) | IL272187B (en) |
| SG (1) | SG11202000593TA (en) |
| TW (1) | TWI728255B (en) |
| WO (1) | WO2019023092A1 (en) |
| ZA (1) | ZA202000439B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3638215A4 (en) | 2017-06-15 | 2021-03-24 | Modernatx, Inc. | Rna formulations |
| MX2020002348A (en) | 2017-08-31 | 2020-10-08 | Modernatx Inc | Methods of making lipid nanoparticles. |
| KR20230170124A (en) | 2018-05-07 | 2023-12-18 | 파모사 바이오팜 인코포레이티드 | Pharmaceutical composition for controlled release of treprostinil |
| AU2019339401B9 (en) * | 2018-09-14 | 2022-11-03 | Pharmosa Biopharm Inc. | Pharmaceutical composition for controlled release of weak acid drugs and uses thereof |
| KR20210149157A (en) * | 2019-05-14 | 2021-12-08 | 파모사 바이오팜 인코포레이티드 | Pharmaceutical composition and administration method of weakly acidic drug |
| IL294866A (en) * | 2020-01-31 | 2022-09-01 | Modernatx Inc | Methods of preparing lipid nanoparticles |
| TW202239408A (en) | 2021-01-29 | 2022-10-16 | 瑞士商艾克泰聯製藥有限公司 | Pharmaceutical composition comprising a diphenylpyrazine derivative |
| WO2023214059A1 (en) | 2022-05-06 | 2023-11-09 | Actelion Pharmaceuticals Ltd | Diphenylpyrazine compounds as prodrugs |
| WO2024017964A1 (en) | 2022-07-20 | 2024-01-25 | Actelion Pharmaceuticals Ltd | Injectable pharmaceutical composition comprising a diphenylpyrazine derivative |
| WO2024067849A1 (en) * | 2022-09-30 | 2024-04-04 | 上海济煜医药科技有限公司 | Liposome pharmaceutical composition, preparation method therefor, and use thereof |
| WO2024067840A1 (en) * | 2022-09-30 | 2024-04-04 | 上海济煜医药科技有限公司 | Liposome, preparation method therefor, and use thereof |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9203808A (en) | 1987-03-05 | 1992-07-01 | Liposome Co Inc | HIGH DRUG CONTENT FORMULATIONS: LIPID, FROM LIPOSOMIC-ANTINEOPLASTIC AGENTS. |
| US5262168A (en) * | 1987-05-22 | 1993-11-16 | The Liposome Company, Inc. | Prostaglandin-lipid formulations |
| US5811118A (en) * | 1987-05-22 | 1998-09-22 | The Liposome Company, Inc. | Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
| IL91664A (en) * | 1988-09-28 | 1993-05-13 | Yissum Res Dev Co | Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release |
| US5088499A (en) | 1989-12-22 | 1992-02-18 | Unger Evan C | Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
| US5149319A (en) | 1990-09-11 | 1992-09-22 | Unger Evan C | Methods for providing localized therapeutic heat to biological tissues and fluids |
| DE69113640T2 (en) | 1991-07-03 | 1996-03-07 | Vestar Inc | LOADING TECHNOLOGY FOR THE PRODUCTION OF LIPOSOMES CONTAINING DRUGS. |
| US5626219A (en) | 1994-11-08 | 1997-05-06 | Sortex Limited | Apparatus and method for stabilising material transported on conveyor belts |
| US5972379A (en) * | 1995-02-14 | 1999-10-26 | Sequus Pharmaceuticals, Inc. | Liposome composition and method for administering a quinolone |
| AU4981896A (en) * | 1995-02-14 | 1996-09-04 | Sequus Pharmaceuticals, Inc. | Liposome composition and method for administering liposome-loadable drugs |
| WO1996032930A1 (en) | 1995-04-18 | 1996-10-24 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Liposome drug-loading method and composition |
| JPH10130169A (en) | 1997-06-26 | 1998-05-19 | Imarx Pharmaceut Corp | Ultrasonotherapeutic composition |
| US7744920B2 (en) | 2004-09-09 | 2010-06-29 | Hadasit Medical Research Services & Development Limited | Use of liposomal glucocorticoids for treating inflammatory states |
| US8318198B1 (en) | 2004-10-05 | 2012-11-27 | Gp Medical, Inc. | Pharmaceutical composition of nanoparticles |
| US8318200B1 (en) | 2004-10-05 | 2012-11-27 | Gp Medical, Inc. | Pharmaceutical composition of nanoparticles |
| TW200618820A (en) * | 2004-11-05 | 2006-06-16 | Alza Corp | Liposome formulations of boronic acid compounds |
| WO2007049279A2 (en) * | 2005-10-26 | 2007-05-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | A liposomal combination and uses thereof |
| WO2007049278A2 (en) * | 2005-10-26 | 2007-05-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | A method for preparing liposomes and uses thereof |
| EP2004141A2 (en) | 2006-03-17 | 2008-12-24 | Novosom AG | An efficient method for loading amphoteric liposomes with nucleic acid active substances |
| WO2009073193A2 (en) * | 2007-12-03 | 2009-06-11 | The Johns Hopkins University | Methods of synthesis and use of chemospheres |
| US20130052259A1 (en) * | 2010-02-01 | 2013-02-28 | Yechezkel Barenholz | Liposomes comprising amphipathic drugs and method for their preparation |
| CA2836317A1 (en) * | 2011-05-16 | 2012-11-22 | Rasmus Irming Jolck | Charge triggering of self-organized nanoparticles |
| ES2819059T3 (en) | 2011-07-13 | 2021-04-14 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Liposomes that jointly encapsulate a bisphosphonate and an amphipathic agent |
| WO2014085813A1 (en) | 2012-11-30 | 2014-06-05 | Insmed Incorporated | Prostacylin compositions and methods for using the same |
| CN104984367B (en) | 2015-04-09 | 2017-12-05 | 重庆医科大学 | A kind of aerogenesis photoacoustic imaging contrast agent and preparation method thereof |
| TWI754659B (en) * | 2016-08-08 | 2022-02-11 | 台灣微脂體股份有限公司 | Delivery vehicle, method and kit for preparing a liposomal composition containing mild acidic agent |
-
2018
- 2018-07-23 SG SG11202000593TA patent/SG11202000593TA/en unknown
- 2018-07-23 CA CA3070951A patent/CA3070951C/en active Active
- 2018-07-23 CN CN201880049079.3A patent/CN111372580A/en active Pending
- 2018-07-23 BR BR112020001411-7A patent/BR112020001411A2/en unknown
- 2018-07-23 EP EP18838053.9A patent/EP3658134A4/en active Pending
- 2018-07-23 US US16/043,126 patent/US11964050B2/en active Active
- 2018-07-23 KR KR1020207001608A patent/KR102337566B1/en active IP Right Grant
- 2018-07-23 TW TW107125393A patent/TWI728255B/en active
- 2018-07-23 WO PCT/US2018/043221 patent/WO2019023092A1/en unknown
- 2018-07-23 AU AU2018307509A patent/AU2018307509B2/en active Active
- 2018-07-23 JP JP2020503870A patent/JP6974670B2/en active Active
- 2018-07-23 IL IL272187A patent/IL272187B/en unknown
-
2020
- 2020-01-22 ZA ZA2020/00439A patent/ZA202000439B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112020001411A2 (en) | 2020-07-28 |
| EP3658134A4 (en) | 2021-05-05 |
| CA3070951A1 (en) | 2019-01-31 |
| WO2019023092A1 (en) | 2019-01-31 |
| AU2018307509B2 (en) | 2021-04-29 |
| RU2020102279A (en) | 2021-08-24 |
| EP3658134A1 (en) | 2020-06-03 |
| AU2018307509A1 (en) | 2020-02-13 |
| TWI728255B (en) | 2021-05-21 |
| IL272187B (en) | 2022-08-01 |
| JP6974670B2 (en) | 2021-12-01 |
| JP2020528432A (en) | 2020-09-24 |
| IL272187A (en) | 2020-03-31 |
| ZA202000439B (en) | 2022-07-27 |
| TW201907908A (en) | 2019-03-01 |
| US20190022004A1 (en) | 2019-01-24 |
| KR102337566B1 (en) | 2021-12-14 |
| CA3070951C (en) | 2023-03-21 |
| US11964050B2 (en) | 2024-04-23 |
| KR20200016976A (en) | 2020-02-17 |
| RU2020102279A3 (en) | 2021-09-23 |
| CN111372580A (en) | 2020-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202000439B (en) | Liposome compositions comprising weak acid drugs and uses thereof | |
| IL262495B (en) | Isoquinoline-3-carboxamide derivatives and pharmaceutical compositions comprising them | |
| HK1257373A1 (en) | Dual function proteins and pharmaceutical composition comprising same | |
| HK1251153A1 (en) | Pharmaceutical composition and application thereof | |
| EP3603620A4 (en) | Liposome composition and pharmaceutical composition | |
| HK1252026A1 (en) | Pharmaceutical combination and uses thereof | |
| EP3310376A4 (en) | Modified therapeutic agents and compositions thereof | |
| EP3434285A4 (en) | Pharmaceutical composition and use thereof | |
| HK1245086A1 (en) | Pharmaceutical composition preparation and uses thereof | |
| EP3175847A4 (en) | Pharmaceutical composition containing leuprolide and having both immediate and sustained release properties | |
| IL266132B (en) | Pharmaceutical formulations and methods of making the same | |
| HK1245085A1 (en) | Pharmaceutical composition preparation and uses thereof | |
| PL3658122T3 (en) | Pharmaceutical composition comprising sacubitril and valsartan | |
| SG10202008700VA (en) | α-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
| EP3347022A4 (en) | Pharmaceutical composition including dutasteride and capsule formulation comprising the same | |
| SG11201803027PA (en) | Compositions comprising phospholipid and their use | |
| GB2546439B (en) | Ezrin-derived peptides and pharmaceutical compositions thereof | |
| HK1245113A1 (en) | Pharmaceutical compositions and use thereof | |
| SG11201803025VA (en) | Compositions comprising vitamins and their use | |
| FI3373976T3 (en) | Topical formulations and uses thereof | |
| EP3269709A4 (en) | N-phenyl-n'-phenoxycarbonyl-phenylsulfonhydrazide derivative and pharmaceutical composition comprising same | |
| EP3399990A4 (en) | Therapeutic compositions including peptides and uses thereof | |
| ZA201903341B (en) | Pharmaceutical compositions and uses thereof | |
| GB201713920D0 (en) | Pharmaceutical compositions and uses thereof | |
| GB201511863D0 (en) | Pharmaceutical compositions comprising hexaminolevulnic acid and methods of using the same |